Live feed
Filing
SC 13D/A
SC 13D/A0001104659-22-131391·Achilles Therapeutics plc
Schedule 13D ownership disclosure
ACHILLES THERAPEUTICS PLC
Security class unavailable · CUSIP: 00449L102
Event date: 2022-12-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,607,834
- Percent of class
- 3.9300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-131391
- Form type
- SC 13D/A
- Filer
- Achilles Therapeutics plc
- CIK
- CIK 1830749
- Filed
- Dec 30, 2022
- Reporting period
- Dec 28, 2022
- Description
- Schedule 13D beneficial ownership